Recursion Announces Incoming CMO Vicki Goodman, M.D., as David Mauro Transitions Out of Role

Recursion has announced Vicki Goodman, M.D., as its incoming Chief Medical Officer, effective April 6. Goodman brings a rare perspective of translating scientific promise into successful clinical programs, with experience in biotech and large pharma, and expertise in oncology. She will help advance Recursion's clinical pipeline and deliver differentiated medicines for patients.